Vigil Neuroscience Inc.

NASDAQ: VIGL · Real-Time Price · USD
8.05
0.00 (0.00%)
At close: Aug 04, 2025, 3:59 PM

Vigil Neuroscience Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
453K 399K 1.01M 345K
Gross Profit
-453K -399K -1.01M -345K
Operating Income
-89.68M -88.87M -68.88M -42.41M
Interest Income
5.42M n/a 623K 3K
Pretax Income
-84.26M -82.64M -68.31M -43.28M
Net Income
-84.26M -82.64M -67.73M -43.25M
Selling & General & Admin
27.38M 27.93M 21.44M 10.08M
Research & Development
62.31M 60.93M 47.44M 32.33M
Other Expenses
n/a n/a -44K n/a
Operating Expenses
89.68M 88.87M 68.88M 42.41M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
89.68M 88.87M 68.88M 42.41M
Income Tax Expense
n/a n/a -579K -31K
Shares Outstanding (Basic)
40.67M 38.71M 31.69M 27.46M
Shares Outstanding (Diluted)
40.67M 38.71M 31.69M 27.46M
EPS (Basic)
-2.07 -2.13 -2.14 -1.57
EPS (Diluted)
-2.07 -2.13 -2.14 -1.57
EBITDA
-83.8M -88.47M -67.3M -42.94M
EBIT
-84.26M -88.87M -68.88M -42.41M
Depreciation & Amortization
453K 399K 1.01M 345K